Drug Type Small molecule drug |
Synonyms 14-O-phosphonooxymethyltriptolide-disodium-salt, MINNELIDE-001 |
Mechanism HSP70 heat-shock proteins inhibitors(HSP70 heat-shock proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC21H27Na2O10P |
InChIKeyYBUXUYKSSJFLBE-KIKMAQITSA-N |
CAS Registry1254702-87-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | US | 01 May 2019 | |
Pancreatic Cancer | Phase 2 | US | 10 Apr 2017 | |
Stomach Cancer | Phase 2 | - | - | |
Secondary malignant neoplasm of pancreas | Phase 1 | KR | 01 Nov 2022 | |
Advanced Gastric Adenocarcinoma | Phase 1 | KR | 02 Nov 2020 | |
Refractory acute myeloid leukemia | Phase 1 | - | 01 Apr 2018 | |
Relapsing acute myeloid leukemia | Phase 1 | - | 01 Apr 2018 | |
Advanced cancer | Phase 1 | US | 10 Oct 2017 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 10 Oct 2017 | |
Breast Cancer | Phase 1 | US | 10 Oct 2017 |
Phase 1 | - | tpeinrfbfj(czorqivxhe) = hphhzvbpor pjgnzzkqqi (ndctfmnmxm ) View more | Positive | 24 May 2024 | |||
Minnelide + Paclitaxel | tpeinrfbfj(czorqivxhe) = gblkfeexky pjgnzzkqqi (ndctfmnmxm ) View more | ||||||
ASCO_GI2023 Manual | Phase 1 | 22 | hzxtpqxskn(wkdtmnehbc) = ubmsqxvoyv vxkfbxlall (blxwuhobba ) View more | Positive | 24 Jan 2023 | ||
hzxtpqxskn(wkdtmnehbc) = mvgqohihwr vxkfbxlall (blxwuhobba ) View more |